Norges Bank’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,137,368
Closed -$454M 2406
2014
Q4
$454M Sell
2,137,368
-37,665
-2% -$7.49M 0.23% 84
2014
Q3
$388M Sell
2,175,033
-2,175,033
-50% -$361M 0.21% 93
2014
Q2
$736M Buy
4,350,066
+2,238,124
+106% +$348M 0.2% 99
2014
Q1
$262M Hold
2,111,942
0.15% 140
2013
Q4
$235M Sell
2,111,942
-237,570
-10% -$22.7M 0.14% 153
2013
Q3
$213M Sell
2,349,512
-64,828
-3% -$5.82M 0.12% 161
2013
Q2
$203M Buy
+2,414,340
New +$250M 0.13% 161

Other funds holding AGN

Norges Bank's AGN Position: Q1 2015 in Review

Norges Bank sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,137,368 shares — an estimated $454M sold.

Norges Bank first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $736M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Norges Bank reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Norges Bank sold 2,137,368 Allergan Inc shares in Q1 2015, an estimated $454M.
  • Norges Bank first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Norges Bank's Allergan Inc position peaked at $736M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Norges Bank's 13F filing for Q1 2015, filed 11 May 2015.